Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I trial of myeloablative conditioning with 3-day total marrow and lymphoid irradiation for leukemia.
Ogawa H, Konishi T, Najima Y, Kito S, Hashimoto S, Kato C, Sakai S, Kanbara Y, Atsuta Y, Konuma R, Wada A, Murakami D, Nakasima S, Uchibori Y, Onai D, Hamamura A, Nishijima A, Shingai N, Toya T, Shimizu H, Kobayashi T, Ohashi K, Doki N, Murofushi KN. Ogawa H, et al. Among authors: wada a. Cancer Sci. 2023 Feb;114(2):596-605. doi: 10.1111/cas.15611. Epub 2022 Nov 2. Cancer Sci. 2023. PMID: 36221800 Free PMC article. Clinical Trial.
Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide.
Yoshifuji K, Toya T, Adachi H, Fujita M, Wada A, Konuma R, Kishida Y, Konishi T, Nagata A, Yamada Y, Kaito S, Kumagai T, Inamoto K, Akiyama M, Igarashi A, Najima Y, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Yoshifuji K, et al. Among authors: wada a. Int J Hematol. 2019 Jul;110(1):115-118. doi: 10.1007/s12185-019-02622-0. Epub 2019 Apr 13. Int J Hematol. 2019. PMID: 30989487
Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation.
Kaito S, Sekiya N, Najima Y, Suzuki T, Wada A, Adachi H, Konuma R, Kishida Y, Nagata A, Konishi T, Yamada Y, Kumagai T, Inamoto K, Yoshifuji K, Akiyama M, Toya T, Igarashi A, Muto H, Doki N, Kobayashi T, Kakihana K, Ohashi K. Kaito S, et al. Among authors: wada a. Bone Marrow Transplant. 2020 Mar;55(3):661-664. doi: 10.1038/s41409-019-0541-1. Epub 2019 May 29. Bone Marrow Transplant. 2020. PMID: 31142797 No abstract available.
Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation.
Kaito S, Wada A, Adachi H, Konuma R, Kishida Y, Nagata A, Konishi T, Yamada Y, Kumagai T, Yoshifuji K, Mukae J, Akiyama M, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Ohashi K, Sakamaki H, Doki N. Kaito S, et al. Among authors: wada a. Ann Hematol. 2020 Jul;99(7):1655-1665. doi: 10.1007/s00277-020-04089-0. Epub 2020 Jun 10. Ann Hematol. 2020. PMID: 32524200
Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: a prospective pilot study.
Konishi T, Ogawa H, Najima Y, Hashimoto S, Wada A, Adachi H, Konuma R, Kishida Y, Nagata A, Yamada Y, Kaito S, Mukae J, Marumo A, Noguchi Y, Toya T, Igarashi A, Kobayashi T, Ohashi K, Doki N, Karasawa K. Konishi T, et al. Among authors: wada a. J Radiat Res. 2020 Nov 16;61(6):969-976. doi: 10.1093/jrr/rraa078. J Radiat Res. 2020. PMID: 32888029 Free PMC article.
[Vacuolar myelopathy after allogeneic bone marrow transplantation in a patient with acute lymphoblastic leukemia].
Kumagai T, Doki N, Kobayashi T, Yamada R, Hishima T, Adachi H, Konuma R, Fujita M, Wada A, Kishida Y, Konishi T, Nagata A, Yamada Y, Kaito S, Yoshifuji K, Mukae J, Akiyama M, Inamoto K, Toya T, Igarashi A, Najima Y, Kakihana K, Sakamaki H, Ohashi K. Kumagai T, et al. Among authors: wada a. Rinsho Ketsueki. 2020;61(11):1625-1627. doi: 10.11406/rinketsu.61.1625. Rinsho Ketsueki. 2020. PMID: 33298658 Japanese.
T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation.
Toya T, Taguchi A, Kitaura K, Misumi F, Nakajima Y, Otsuka Y, Konuma R, Adachi H, Wada A, Kishida Y, Konishi T, Nagata A, Yamada Y, Marumo A, Noguchi Y, Yoshifuji K, Mukae J, Inamoto K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Ohashi K, Suzuki R, Nagamatsu T, Doki N. Toya T, et al. Among authors: wada a. Sci Rep. 2020 Dec 17;10(1):22218. doi: 10.1038/s41598-020-79363-2. Sci Rep. 2020. PMID: 33335252 Free PMC article.
Changes in vaccination strategies contribute to the development of invasive pneumococcal disease in allogeneic hematopoietic stem cell transplantation recipients: a retrospective study for promoting vaccination.
Konishi T, Sekiya N, Otsuka Y, Konuma R, Wada A, Adachi H, Kishida Y, Nagata A, Yamada Y, Noguchi Y, Marumo A, Mukae J, Inamoto K, Toya T, Igarashi A, Najima Y, Kobayashi T, Sakamaki H, Ohashi K, Doki N. Konishi T, et al. Among authors: wada a. Int J Hematol. 2021 Aug;114(2):263-270. doi: 10.1007/s12185-021-03146-2. Epub 2021 Apr 12. Int J Hematol. 2021. PMID: 33846960
Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBI.
Yamada Y, Ikegawa S, Najima Y, Atsuta Y, Konuma R, Adachi H, Wada A, Kishida Y, Konishi T, Nagata A, Kaito S, Nagata R, Noguchi Y, Marumo A, Mukae J, Inamoto K, Toya T, Igarashi A, Kobayashi T, Sakamaki H, Ohashi K, Doki N. Yamada Y, et al. Among authors: wada a. Int J Hematol. 2022 Feb;115(2):244-254. doi: 10.1007/s12185-021-03233-4. Epub 2021 Oct 15. Int J Hematol. 2022. PMID: 34652634
1,598 results